Management and outcome of French elderly patients with lung cancer: An IFCT survey;IFCT 02-02: La prise en charge du cancer bronchique chez les patients âgés de 70 ans et plus en France

Revue des Maladies Respiratoires

Volumn 27, Issue 5, 2010, Pages 421-430

  Quoix, E ^a   Monnet, I ^b   Scheid, P ^c   Hamadouche, A ^d   Chouaid, C ^e   Massard, G ^a   Depierre, A ^f   Souquet, P J ^g   Braun, D ^h   Girard, P ⁱ   Breton, J L ^j   Lebitasy, M P ^k   Milleron, B ^l  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c CHU NANCY BRABOIS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h CHG de Briey   (France)

ⁱ INSTITUT MUTUALISTE MONTSOURIS   (France)

^j CHG de Belfort   (France)

^k IFCT   (France)

^l HÔPITAL TENON   (France)

more..

Author keywords

Early death; Elderly; Lung cancer; Management; Smoking habits

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL;

AGED; ARTICLE; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; SMOKING HABIT;

AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HEALTH CARE SURVEYS; HUMANS; LUNG NEOPLASMS; MALE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77955013704     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmr.2010.02.013     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Baldini EH, Strauss GM. Women and lung cancer: waiting to exhale. Chest 1997;112:229S-34S.
3. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008;56:159-175
4. Levi F, La Vecchia C, Lucchini F, Negri E. Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur J Cancer 1996;32A:652-672
5. Lebitasy MP, Hedelin G, Purohit A, Moreau L, Klinzig F, Quoix E. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer 2001;85:808-815
6. Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001;56:212-217
7. Foegle J, Hedelin G, Lebitasy MP, Purohit A, Velten M, Quoix E. Non-small-cell lung cancer in a French department (1982-1997): management and outcome. Br J Cancer 2005;92:459-466
8. Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal or non-small- cell lung cancer in chemotherapy trials. Intern Med J 2006;36:216-220
9. Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Benichou-Flurin M, et al. Epidemiologic of primary bronchial carcinoma management in the general French hospital centers. RevMal Respir 2002;19:727-734
10. Yee KW, Pater JL, Pho L, Zee B, Siu LL. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? J Clin Oncol 2003;21:1618-1623
11. Hutchins LF, Unger JM, Crowley JJ, Coltman Jr. CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341: 2061-2067
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-383
13. Hosmer W, Malin J, Wong M. Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer. Support Care Cancer 2010 Feb 24 [Epub ahead of print]
14. Balducci L. Geriatric oncology: challenges for the new century. Eur J Cancer 2000;36:1741-1754
15. Piquet J, Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, et al. Primary lung cancer in elderly subjects in France. Rev Mal Respir 2004;21(8):S70-8.
16. OwonikokoTK, RaginCC, BelaniCP, Oton AB, Gooding WE, Taioli E, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007;25:5570-5577
17. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51:3-30. (Pubitemid 36813955)
18. Rezvani A, Mollie A, Doyon F. Atlas de la mortalite par cancer en France: periode 1986-1993. In: Inserm (ed.), Statistiques de sante, vol.21. Inserm; 1997, p. 147.
19. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-513
20. Foegle J, Hedelin G, Lebitasy M, Purohit A, Velten M, Quoix E. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982-1997. J Thoracic Oncol 2007;2:466-474
21. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000;36:453-471
22. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999;86:1867-1876
23. Mahmud SM, Reilly M, Comber H. Patterns of initial management of lung cancer in the Republic of Ireland: a population-based study. Lung Cancer 2003;41:57-64.
24. Oxnard GR, Fidias P, Muzikansky A, Sequist LV. Non-small cell lung cancer in octogenarians: treatment practices and preferences. J Thorac Oncol 2007;2:1029-1035
25. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, et al. Who gets chemotherapy for metastatic lung cancer? Chest 2000;117:1239-1246
26. Gridelli C, Shepherd FA. Chemotherapy for elderly patients with non-small cell lung cancer: a review of the evidence. Chest 2005;128:947-957 (Pubitemid 41140531)
27. Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker Jr. S, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-353 [Epub 2003, Dec 22].
28. Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, Mckenzie M, et al. New combination of the old drugs for elderly patients with small cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 1998;16:1940-1947
29. Weinmann M, Jeremic B, Bamberg M, Bokemeyer C. Treatment of lung cancer in elderly part II: small cell lung cancer. Lung Cancer 2003;40:1-16. (Pubitemid 36344062)
30. Quoix E, Breton JL, Daniel C, Jacoulet P, Debieuvre D, Paillot N, et al. Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study. Ann Oncol 2001;12:957-962
31. Albain K, Crowley J, Le Blanc M, Livingston RG. Survival determinants in extensive-stage non small cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991;9:1618-1626
32. Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, et al. Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analysis including RECPAM in 1052 patients. J Clin Oncol 1995;13:1221-1230
33. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13:1087-1093
34. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, et al. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the Mayo Clinic Lung Cancer Cohort. Oncologist 2007;12: 1456-1463
35. Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, et al. A prognostic model for advanced stage nons- mall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 2006;107:781-792
36. Toh C, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, et al. Never- smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006;24:2245-2251
37. Thomas P, Piraux M, Jacques LF, Gregoire J, Bedard P, Des- lauriers J. Clinical patterns and trends of outcome of elderly patients with bronchogenic carcinoma. Eur J Cardiothorac Surg 1998;13:266-274